With legalization of cannabis across much of the United States and all of Canada, Don Sin, MD, FRCP, MPH, a professor of respiratory medicine at the University of British Columbia and head of the Centre of Heart Lung Innovation, St. Paul’s Hospital, has concerns about the effect of wider cannabis usage on chronic obstructive pulmonary disease (COPD) in future decades.
With legalization of cannabis across much of the United States and all of Canada, Don Sin, MD, FRCP, MPH, a professor of respiratory medicine at the University of British Columbia and head of the Centre of Heart Lung Innovation, St. Paul’s Hospital, has concerns about the effect of wider cannabis usage on chronic obstructive pulmonary disease (COPD) in future decades.
Transcript
Looking ahead decades, since we know COPD incidence is already expected to grow, are there fears about what the growing legalization of cannabis will mean for COPD?
If you look at the composition of cannabis, the real difference between cannabis and cigarettes, tobacco cigarettes, is the active component. So you're really replacing nicotine with THC in the case of cannabis, but the rest of the chemicals inside a cannabis inhalant is very similar to tobacco cigarettes. In fact, some have suggested that we should call cannabis as marijuana cigarettes, just because the constituents are very, very similar. So in the case of tobacco smoke, we don't know which chemicals actually cause COPD or lung cancer and other adverse effects. I think we're potentially playing a very dangerous game with widespread use of cannabis as an inhalant because the chemical composition is so similar to that of tobacco cigarettes. Of course, we don't have a lot of data right now, because the prevalence of cannabis smoking has not been that high over the past 20 years. But now with legalization and, you know, wider social acceptance of cannabis, it's really skyrocketing, particularly among young individuals, young adults. So I'm fearful that in 20 years, we may be having this interview and saying, you know, cannabis is associated with COPD, with lung cancer, and all the bad things that we have associated with tobacco cigarettes.
Enhancing Outpatient Hemophilia Care May Improve Health Outcomes and Costs
May 18th 2024Prospective data from patients attending a rural practice in West Virginia between 2016 and 2023 show that a quality improvement program that followed guideline recommendations and was tailored to specific patient needs reduced preventable bleeds and lowered costs.
Read More
Health Equity and Access Weekly Roundup: May 18, 2024
May 18th 2024The US Senate hosted a panel addressing physician and health care shortages and efforts to increase minority representation in the medical field. An expert discussed initiatives to prevent senior homelessness. Advocates called for the repeal of the Comstock Act. Regulatory reforms are called for to improve rural cancer patients' access to pharmacies. Research reveals the impact of denials on patient access to immunology treatments.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Covering antiobesity medications like semaglutide could save Medicare around $500 million annually; preliminary CDC data showed a 3% decline in the number of US overdose deaths last year; the Biden administration recently announced the first national maternal mental health strategy.
Read More
Congress Urged to Repeal Comstock Act Threatening Reproductive Rights and Public Health
May 16th 2024In a joint letter addressed to Congress, Healthcare Across Borders, Take Back the Court Action Fund, and UltraViolet Action called out the resurgence of the Comstock Act, urging immediate action to repeal this century-old law that threatens reproductive rights and public health in the US.
Read More